Insights

Innovative Drug Platforms Viva Biotech's recent launch of their AI-Driven Drug Discovery platform and V-DEL technology demonstrates a strong focus on cutting-edge solutions, making them an attractive partner for pharmaceutical companies seeking advanced drug development capabilities.

Strategic Industry Recognition Winning awards such as the 2025 APAC Technology Innovation Leadership and Influential Preclinical CRO Company of the Year positions Viva Biotech as a recognized leader in pharmaceutical R&D, increasing its credibility and attractiveness to potential clients.

Growth and Funding With substantial funding of approximately $210 million and revenue estimates between $100 million and $250 million, Viva Biotech is well-positioned for expansion, offering opportunities for partners looking to collaborate in emerging biotech and pharma markets.

Technology Integration Viva Biotech's integration with NVIDIA and adoption of state-of-the-art technologies like Cryo-EM, CADD, and high-throughput screening enables scalable, innovative drug discovery services that appeal to companies seeking efficient R&D solutions.

Comprehensive Service Portfolio Offering end-to-end services from early-stage research to commercial manufacturing and CMC, Viva Biotech is positioned as a one-stop partner for pharmaceutical innovators, creating opportunities for collaborative development and long-term partnerships across the drug lifecycle.

Viva Biotech Tech Stack

Viva Biotech uses 8 technology products and services including Open Graph, Swiper, jQuery, and more. Explore Viva Biotech's tech stack below.

  • Open Graph
    Content Management System
  • Swiper
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Wow
    Marketing Analytics
  • HubSpot
    Marketing Automation
  • Google Analytics
    Web Analytics
  • Tengine
    Web And Application Servers
  • jQuery Waypoints
    Web Tools And Plugins

Media & News

Viva Biotech's Email Address Formats

Viva Biotech uses at least 1 format(s):
Viva Biotech Email FormatsExamplePercentage
First.Last@vivabiotech.comJohn.Doe@vivabiotech.com
71%
Last.First@vivabiotech.comDoe.John@vivabiotech.com
12%
FirLast@vivabiotech.comJohDoe@vivabiotech.com
9%
FirstLast@vivabiotech.comJohnDoe@vivabiotech.com
8%

Frequently Asked Questions

Where is Viva Biotech's headquarters located?

Minus sign iconPlus sign icon
Viva Biotech's main headquarters is located at 735号 紫萍路 Shanghai, Shanghai 201318 China. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is Viva Biotech's official website and social media links?

Minus sign iconPlus sign icon
Viva Biotech's official website is vivabiotech.com and has social profiles on LinkedInCrunchbase.

What is Viva Biotech's SIC code NAICS code?

Minus sign iconPlus sign icon
Viva Biotech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Viva Biotech have currently?

Minus sign iconPlus sign icon
As of March 2026, Viva Biotech has approximately 173 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Business Officer And Executive Vice President: X. B.Chief Innovation Officer, Head Of Investment: H. D.Chief Technology Officer: L. C.. Explore Viva Biotech's employee directory with LeadIQ.

What industry does Viva Biotech belong to?

Minus sign iconPlus sign icon
Viva Biotech operates in the Biotechnology Research industry.

What technology does Viva Biotech use?

Minus sign iconPlus sign icon
Viva Biotech's tech stack includes Open GraphSwiperjQueryWowHubSpotGoogle AnalyticsTenginejQuery Waypoints.

What is Viva Biotech's email format?

Minus sign iconPlus sign icon
Viva Biotech's email format typically follows the pattern of First.Last@vivabiotech.com. Find more Viva Biotech email formats with LeadIQ.

How much funding has Viva Biotech raised to date?

Minus sign iconPlus sign icon
As of March 2026, Viva Biotech has raised $210M in funding. The last funding round occurred on Jun 13, 2023 for $210M.

When was Viva Biotech founded?

Minus sign iconPlus sign icon
Viva Biotech was founded in 2008.

Viva Biotech

Biotechnology ResearchShanghai, China51-200 Employees

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD and CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

Section iconCompany Overview

Headquarters
735号 紫萍路 Shanghai, Shanghai 201318 China
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $210M

    Viva Biotech has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $210M.

  • $100M$250M

    Viva Biotech's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $210M

    Viva Biotech has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $210M.

  • $100M$250M

    Viva Biotech's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.